맞춤형 영양(Personalized Nutrition) 시장 예측(-2030년) : 제품(제품, 서비스, 디지털 툴), 용도(일반 라이프스타일, 미용, 피부 및 장수, 체중 관리 및 대사 건강), 최종사용자, 퍼스널라이제이션 기준, 유형, 지역별

The market for personalized nutrition is estimated to be USD 15.79 billion in 2025 and is projected to reach USD 30.94 billion by 2030, at a CAGR of 14.4% during the forecast period. The personalized nutrition market is expanding rapidly, driven by rising consumer awareness of health, preventive healthcare, and technological advancements in genomics and digital health platforms. Consumers increasingly demand customized diet plans, supplements, and functional foods tailored to individual genetics, lifestyle, and health conditions.

North America leads due to its high healthcare spending and the adoption of digital solutions, while the Asia Pacific is the fastest-growing region, fueled by urbanization and the prevalence of chronic diseases. Key players include food, nutraceutical, and tech companies offering DNA-based testing, mobile apps, and wearable integration. Despite opportunities, high costs and regulatory complexities remain challenges to market growth.

"The beauty, skin, & longevity application segment is projected to register a significant CAGR during the forecast period."

The beauty, skin, & longevity segment is emerging as the fastest-growing application within the personalized nutrition market, fueled by the rising convergence of wellness, aesthetics, and preventative healthcare. Consumers are increasingly shifting toward holistic approaches that address not only external beauty but also internal health, with nutrition playing a central role in supporting skin vitality, hair strength, and healthy aging. Advances in nutrigenomics, microbiome analysis, and digital diagnostics are enabling companies to create tailored solutions such as collagen-based supplements, antioxidant-rich formulations, and personalized vitamin blends that cater to individual needs for skin elasticity, hydration, and anti-aging benefits. Younger demographics, particularly millennials and Gen Z, are driving demand for preventive beauty solutions that integrate nutrition into daily self-care routines, while aging populations are seeking longevity-focused interventions to maintain quality of life.

"By personalization basis, the microbiome-based personalization segment is projected to witness a significant CAGR during the forecast period."

Growing scientific evidence linking gut health with immunity, metabolic function, mental wellbeing, and skin vitality has created strong consumer interest in microbiome-targeted solutions. With the human microbiome being unique to each individual, companies are leveraging advanced sequencing technologies and AI-driven analysis to provide customized dietary supplements, probiotics, prebiotics, and functional foods tailored to specific microbiome profiles. Rising incidence of lifestyle-related disorders, such as obesity, diabetes, and gastrointestinal issues, is further fueling demand for microbiome-based interventions as consumers look for natural, preventive, and scientifically validated options. The segment also benefits from rapid innovation, including at-home microbiome testing kits, integration with digital platforms, and real-time data collection that translates into actionable dietary recommendations.

"Asia Pacific is expected to exhibit the fastest growth rate during the forecast period."

The Asia Pacific (APAC) region is projected to be the fastest-growing market for personalized nutrition between 2025 and 2030, driven by rapid urbanization, rising disposable incomes, and a growing middle-class population increasingly focused on preventive healthcare and wellness. The region faces a dual challenge of escalating lifestyle-related diseases such as diabetes, obesity, and cardiovascular disorders, alongside strong cultural traditions linking diet with health, making it a fertile ground for personalized solutions. Consumers in countries like China, Japan, South Korea, and India are embracing digital health platforms, wearable devices, and at-home testing kits that provide customized dietary and supplement recommendations. Japan and South Korea lead in technological adoption, with advanced integration of nutrigenomics, microbiome testing, and functional foods, while China is seeing a surge in demand through e-commerce and direct-to-consumer personalized nutrition products. India and Southeast Asia are emerging hotspots due to rising awareness of nutrition-related disorders and the increasing penetration of mobile health apps.

In-depth interviews were conducted with chief executive officers (CEOs), directors, and other executives from various key organizations operating in the personalized nutrition market:

• By Company Type: Tier 1 - 25%, Tier 2 - 45%, and Tier 3 - 30%
• By Designation: CXOs - 20%, Managers - 50%, Executives- 30%
• By Region: North America - 25%, Europe - 30%, Asia Pacific - 20%, South America - 15%, and Rest of the World -10%

Prominent companies in the market include Abbott (US), Nestle Health Science (Switzerland), Medtronic (Ireland/US operations), 23andMe (US), Prenetics (Hong Kong), ZOE (UK), Viome (US), InsideTracker (US), Nutrigenomix (Canada), and Nature's Way (US).

Other players include Rootine (US), Sun Genomics (US), Seed Health (US), EatLove (US), Suggestic (US), Noom (US), Oviva (Switzerland/UK), SelfDecode (US), GenoPalate (US), Orig3n (US), Superpower (US), Alba Health (US), Season Health (US), Levels (US), Nutripal (India), Nutrigenie (US), myDNA (Australia), CarePredict (US), and Thryve (US).

Research Coverage:

This research report categorizes the personalized nutrition market by product (products, services, digital tools/platforms), application (general lifestyle, weight management & metabolic health, sports & fitness performance, clinical nutrition & disease management, life-stage & special populations, beauty, skin, & longevity), personalization basis (general lifestyle genetic/nutrigenomic, microbiome-based, biomarker/blood-based, physiological/wearable-based, behavioral & dietary log-based, demographic/lifestyle-based), end-use (direct consumers, patient, sports & fitness users, corporate & insurers), type (standard, active), and region (North America, Europe, Asia Pacific, South America, and Rest of the World). The report's scope encompasses detailed information on the major factors, including drivers, restraints, challenges, and opportunities, that influence the market's growth. A detailed analysis of the key industry players has been done to provide insights into their business overview, services, key strategies, contracts, partnerships, agreements, new service launches, mergers and acquisitions, and recent developments associated with the personalized nutrition market. This report covers a competitive analysis of upcoming startups in the personalized nutrition market ecosystem. Furthermore, the study covers industry-specific trends, including technology analysis, ecosystem and market mapping, patent analysis, and regulatory landscape, among others.

Reasons to buy this report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall personalized nutrition market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights into the following points:

• Analysis of key drivers (shift in consumer preferences due to the rise in health awareness), restraints (inflated cost of personalized testing and nutrition plans), opportunities (increasing innovations and advancements in technologies), and challenges (presence of regulations in the personalized nutrition market) influencing the growth of the personalized nutrition market.
• New Product Launch/Innovation: Detailed insights into research & development activities and new product launches in the personalized nutrition market.
• Market Development: Comprehensive information about lucrative markets - the report analyzes the personalized nutrition across varied regions.
• Market Diversification: Exhaustive information about new services, untapped geographies, recent developments, and investments in the personalized nutrition market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, brand/product comparison, and product food prints of leading players such as Abbott (US), Nestle Health Science (Switzerland), Medtronic (Ireland/USA operations), 23andMe (US), Prenetics (Hong Kong), ZOE (UK), Viome (US), InsideTracker (US), Nutrigenomix (Canada), Nature's Way (US), and other players in the personalized nutrition market.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 INCLUSIONS & EXCLUSIONS
• 1.4 YEARS CONSIDERED
• 1.5 UNITS CONSIDERED
  • 1.5.1 CURRENCY/VALUE UNIT
  • 1.5.2 VOLUME UNIT
• 1.6 STAKEHOLDERS
• 1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key data from primary sources
    • 2.1.2.2 Key insights from industry experts
    • 2.1.2.3 Breakdown of primary profiles
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 APPROACH ONE-BOTTOM-UP (BASED ON SOLUTION TYPE, BY REGION)
  • 2.2.2 APPROACH TWO-TOP-DOWN (BASED ON GLOBAL MARKET)
  • 2.2.3 SUPPLY-SIDE ANALYSIS
• 2.3 DATA TRIANGULATION
• 2.4 RESEARCH ASSUMPTIONS
• 2.5 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 ATTRACTIVE OPPORTUNITIES FOR KEY PLAYERS IN PERSONALIZED NUTRITION MARKET
• 4.2 ASIA PACIFIC PERSONALIZED NUTRITION MARKET, BY SOLUTION TYPE AND COUNTRY
• 4.3 PERSONALIZED NUTRITION MARKET, BY SOLUTION TYPE AND REGION
• 4.4 PERSONALIZED NUTRITION MARKET: SHARE OF MAJOR REGIONAL SUBMARKETS

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MACROECONOMIC INDICATORS
  • 5.2.1 RISING PREVALENCE OF CHRONIC DISEASES
  • 5.2.2 SHIFT IN CONSUMER PREFERENCES DUE TO INCREASING FOCUS ON HEALTH
• 5.3 MARKET DYNAMICS
  • 5.3.1 DRIVERS
    • 5.3.1.1 Rising healthcare burden due to chronic ailments
    • 5.3.1.2 Surge in elderly population and their growing use of dietary supplements
    • 5.3.1.3 Technological advances in omics, wearables, and AI to enable deeper, real-time personalized nutrition insights
    • 5.3.1.4 Preventive healthcare adoption by corporates, insurers, and providers to integrate personalized nutrition into systemic care
    • 5.3.1.5 Growing trend of digital healthcare
  • 5.3.2 RESTRAINTS
    • 5.3.2.1 High costs of active measurement tests and supplements limiting mass-market affordability and adoption
    • 5.3.2.2 Regulatory complexity and restrictions on health claims hindering innovation and marketing effectiveness
  • 5.3.3 OPPORTUNITIES
    • 5.3.3.1 Rising adoption of digital health tools
    • 5.3.3.2 Expansion into corporate wellness and insurer-backed preventive healthcare programs
  • 5.3.4 CHALLENGES
    • 5.3.4.1 Scaling personalization across geographies due to cultural, dietary, and infrastructure differences
    • 5.3.4.2 Consumer engagement and retention due to churning in subscription models
• 5.4 IMPACT OF GENERATIVE AI ON PERSONALIZED NUTRITION MARKET
  • 5.4.1 USE OF GEN AI IN PERSONALIZED NUTRITION MARKET
  • 5.4.2 CASE STUDY ANALYSIS
    • 5.4.2.1 ZOE's Gen AI-Driven Nutrition Coaching Platform
    • 5.4.2.2 AI-Enhanced CGM Insights (Lingo Platform)
    • 5.4.2.3 Viome's AI-driven Personalized Supplement Formulation
  • 5.4.3 IMPACT OF AI ON PERSONALIZED NUTRITION MARKET
  • 5.4.4 IMPACT OF GEN AI ON ADJACENT ECOSYSTEM

6 INDUSTRY TRENDS

• 6.1 INTRODUCTION
• 6.2 VALUE CHAIN ANALYSIS
  • 6.2.1 SAMPLING
  • 6.2.2 TESTING AND ASSESSMENT
  • 6.2.3 INTERPRETATION & RECOMMENDATION
  • 6.2.4 END USE
• 6.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
• 6.4 PRICING ANALYSIS
  • 6.4.1 AVERAGE SELLING PRICE OF NUTRITION TYPES, BY KEY PLAYER, 2024
  • 6.4.2 AVERAGE SELLING PRICE TREND, BY REGION, 2023-2030
• 6.5 ECOSYSTEM ANALYSIS
  • 6.5.1 DEMAND-SIDE
  • 6.5.2 SUPPLY-SIDE
• 6.6 TECHNOLOGY ANALYSIS
  • 6.6.1 KEY TECHNOLOGIES
    • 6.6.1.1 Next-generation Sequencing
    • 6.6.1.2 16S rRNA & Metagenomic Sequencing
  • 6.6.2 COMPLEMENTARY TECHNOLOGIES
    • 6.6.2.1 Continuous Glucose Monitoring
    • 6.6.2.2 AI/ML Nutrition Platforms
  • 6.6.3 ADJACENT TECHNOLOGIES
    • 6.6.3.1 Telehealth & Virtual Nutrition Platforms
    • 6.6.3.2 3D Food Printing & Functional Food Tech
• 6.7 PATENT ANALYSIS
• 6.8 TRADE ANALYSIS
  • 6.8.1 IMPORT SCENARIO OF HS CODE 3822
  • 6.8.2 EXPORT SCENARIO OF HS CODE 3822
• 6.9 KEY CONFERENCES AND EVENTS, 2025-2026
• 6.10 REGULATORY LANDSCAPE
  • 6.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 6.10.2 REGULATORY FRAMEWORK
    • 6.10.2.1 North America
      • 6.10.2.1.1 Canada
      • 6.10.2.1.2 US
      • 6.10.2.1.3 Mexico
  • 6.10.3 EUROPEAN UNION REGULATIONS
    • 6.10.3.1 Asia Pacific
      • 6.10.3.1.1 China
      • 6.10.3.1.2 India
      • 6.10.3.1.3 Australia & New Zealand
    • 6.10.3.2 South America
      • 6.10.3.2.1 Brazil
      • 6.10.3.2.2 Argentina
    • 6.10.3.3 AFRICA
      • 6.10.3.3.1 Functional foods
      • 6.10.3.3.2 Dietary supplements
      • 6.10.3.3.3 Registrations in South Africa
      • 6.10.3.3.4 Composition of supplements in South Africa
    • 6.10.3.4 MIDDLE EAST
• 6.11 PORTER'S FIVE FORCES ANALYSIS
  • 6.11.1 THREAT OF NEW ENTRANTS
  • 6.11.2 THREAT OF SUBSTITUTES
  • 6.11.3 BARGAINING POWER OF SUPPLIERS
  • 6.11.4 BARGAINING POWER OF BUYERS
  • 6.11.5 INTENSITY OF COMPETITIVE RIVALRY
• 6.12 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 6.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 6.12.2 BUYING CRITERIA
• 6.13 INVESTMENT AND FUNDING SCENARIO
• 6.14 CASE STUDY ANALYSIS
  • 6.14.1 NUTRIGENOMIX - CANADA, GENETIC TEST-BASED NUTRITION PLANS
  • 6.14.2 ZOE - UK, MICROBIOME & METABOLIC RESPONSE TESTING
  • 6.14.3 HABIT (ACQUIRED BY VIOME) - USA, BLOOD BIOMARKER-BASED NUTRITION
• 6.15 TARIFF IMPACT ON PERSONALIZED NUTRITION MARKET
  • 6.15.1 INTRODUCTION
  • 6.15.2 KEY TARIFF RATES
  • 6.15.3 DISRUPTIONS IN PERSONALIZED NUTRITION INDUSTRY
  • 6.15.4 PRICE IMPACT ANALYSIS
  • 6.15.5 KEY IMPACTS ON VARIOUS REGIONS
    • 6.15.5.1 US
    • 6.15.5.2 Europe
    • 6.15.5.3 Asia Pacific
  • 6.15.6 END-USE INDUSTRY-LEVEL IMPACT

7 PERSONALIZED NUTRITION MARKET, BY SOLUTION TYPE

• 7.1 INTRODUCTION
• 7.2 PRODUCTS
  • 7.2.1 RISING CONSUMER DEMAND FOR PRECISION HEALTH SOLUTIONS TO INTEGRATE PERSONALIZATION WITH CONVENIENCE AND EFFICACY
  • 7.2.2 PERSONALIZED SUPPLEMENTS
    • 7.2.2.1 Growing reliance on tailored supplement packs addressing deficiencies, lifestyle needs, and preventive health management
    • 7.2.2.2 Customized vitamins & minerals
    • 7.2.2.3 Probiotics and prebiotics
    • 7.2.2.4 Protein and amino acid blends
    • 7.2.2.5 Botanicals and bioactives
    • 7.2.2.6 Omega-3s & Specialty Fats
  • 7.2.3 PERSONALIZED FUNCTIONAL FOODS
    • 7.2.3.1 Growing consumer preference for integrating personalization into everyday diets through foods and beverages
    • 7.2.3.2 Functional foods
    • 7.2.3.3 Custom meal kits
    • 7.2.3.4 Smart beverages
• 7.3 SERVICES
  • 7.3.1 EXPANDING CONSUMER DEMAND FOR PERSONALIZED HEALTH SERVICES TO INTEGRATE DIAGNOSTICS, COACHING, AND INSTITUTIONAL WELLNESS PROGRAMS
  • 7.3.2 TESTING & DIAGNOSTICS
    • 7.3.2.1 Foundational role of diagnostics to unlock data-driven personalization and enable scalable, science-backed solutions
    • 7.3.2.2 Genetic testing kits
    • 7.3.2.3 Microbiome testing kits
    • 7.3.2.4 Blood biomarker tests
    • 7.3.2.5 Allergy tests
  • 7.3.3 COACHING & DIETICIAN CONSULTATION
    • 7.3.3.1 Rising consumer need for guided interpretation of data to drive sustainable health behavioral change
  • 7.3.4 CORPORATE WELLNESS & INSURANCE LINKED PROGRAMS
    • 7.3.4.1 Preventive health economics to drive insurers and employers to embed personalized nutrition
• 7.4 DIGITAL TOOLS/PLATFORMS
  • 7.4.1 TECHNOLOGY INTEGRATION TO TRANSFORM PERSONALIZATION INTO SCALABLE, REAL-TIME, AND INTERACTIVE CONSUMER HEALTH ECOSYSTEMS
  • 7.4.2 MOBILE APPS
  • 7.4.3 WEARABLES & DEVICES
  • 7.4.4 ONLINE PLATFORMS
  • 7.4.5 AI COACH

8 PERSONALIZED NUTRITION MARKET, BY TYPE

• 8.1 INTRODUCTION
• 8.2 ACTIVE
  • 8.2.1 PRECISION, INNOVATION, AND DATA-DRIVEN INSIGHTS TO FUEL ACTIVE MEASUREMENT
• 8.3 STANDARD
  • 8.3.1 ACCESSIBILITY, AFFORDABILITY, AND SCALABILITY TO PROPEL STANDARD MEASUREMENT ADOPTION

9 PERSONALIZED NUTRITION MARKET, BY PERSONALIZATION BASIS

• 9.1 INTRODUCTION
• 9.2 NUTRIGENOMIC
  • 9.2.1 GROWING CONSUMER DEMAND FOR DNA-DRIVEN NUTRITION SOLUTIONS TO BOOST PERSONALIZED HEALTH OUTCOMES
• 9.3 MICROBIOME-BASED
  • 9.3.1 INCREASED CONSUMER AWARENESS TO BOOST IMMUNITY AND METABOLISM
• 9.4 BIOMARKER
  • 9.4.1 RISING DEMAND FOR REAL-TIME, EVIDENCE-BASED NUTRITION SOLUTIONS SUPPORTED BY ACCESSIBLE AT-HOME BLOOD BIOMARKER TESTING
• 9.5 WEARABLE-BASED
  • 9.5.1 RISING ADOPTION OF WEARABLES INTEGRATING NUTRITION INSIGHTS WITH GLUCOSE, SLEEP, ACTIVITY, AND RECOVERY METRICS
• 9.6 BEHAVIORAL & DIETARY LOG-BASED
  • 9.6.1 CONSUMER DEMAND FOR ACCESSIBLE, AFFORDABLE TOOLS TO DRIVE NUTRITION CHANGE THROUGH DIGITAL TRACKING AND BEHAVIORAL COACHING
• 9.7 LIFESTYLE-BASED
  • 9.7.1 GROWING AWARENESS OF POPULATION-SPECIFIC NUTRIENT NEEDS ACROSS AGE, GENDER, FITNESS, AND LIFESTYLE-DRIVEN CONSUMER GROUPS

10 PERSONALIZED NUTRITION MARKET, BY APPLICATION

• 10.1 INTRODUCTION
• 10.2 GENERAL LIFESTYLE
  • 10.2.1 PREVENTIVE WELLNESS & EVERYDAY HEALTH OPTIMIZATION TO DRIVE MARKET
• 10.3 SPORTS & FITNESS PERFORMANCE
  • 10.3.1 RISING ATHLETIC PARTICIPATION AND DEMAND FOR PERFORMANCE OPTIMIZATION
• 10.4 WEIGHT MANAGEMENT & METABOLIC HEALTH
  • 10.4.1 RISING OBESITY EPIDEMIC AND LIFESTYLE-RELATED CHRONIC DISEASES
• 10.5 CLINICAL NUTRITION & DISEASE MANAGEMENT
  • 10.5.1 GROWING CHRONIC DISEASE BURDEN AND INTEGRATION OF DIGITAL THERAPEUTICS
• 10.6 LIFE STAGE & SPECIAL POPULATIONS
  • 10.6.1 RISING DEMAND FOR TAILORED NUTRITION ACROSS LIFE TRANSITIONS
• 10.7 BEAUTY, SKIN, & LONGEVITY
  • 10.7.1 RISING CONSUMER FOCUS ON HOLISTIC WELLNESS AND HEALTHY AGING

11 PERSONALIZED NUTRITION MARKET, BY END USE

• 11.1 INTRODUCTION
• 11.2 DIRECT TO CONSUMERS
  • 11.2.1 CONVENIENCE AND CONSUMER ENGAGEMENT TO BOOST D2C PERSONALIZED NUTRITION
• 11.3 PATIENT/HEALTHCARE USERS
  • 11.3.1 CLINICAL CREDIBILITY AND THERAPEUTIC VALUE TO DRIVE SEGMENT
• 11.4 SPORTS & FITNESS
  • 11.4.1 PERFORMANCE OPTIMIZATION TO BOOST DEMAND FOR PERSONALIZED NUTRITION
• 11.5 CORPORATES & INSURERS
  • 11.5.1 RISK MITIGATION AND WORKFORCE HEALTH TO BOOST ADOPTION

12 PERSONALIZED NUTRITION MARKET, BY BUSINESS MODEL (QUALITATIVE)

• 12.1 INTRODUCTION
• 12.2 DIRECT CONSUMERS ONE-TIME PURCHASE
• 12.3 SUBSCRIPTION
• 12.4 B2B/LICENSING

13 PERSONALIZED NUTRITION MARKET, BY REGION

• 13.1 INTRODUCTION
• 13.2 NORTH AMERICA
  • 13.2.1 US
    • 13.2.1.1 Advancements in AI, availability of rich datasets, and growing public interest in personalized nutrition to drive market
  • 13.2.2 CANADA
    • 13.2.2.1 Supportive healthcare policies and growing focus on long-term health to drive market
  • 13.2.3 MEXICO
    • 13.2.3.1 Rapid DTC & retail expansion amid regulatory tightening and public-health demand to drive market
• 13.3 ASIA PACIFIC
  • 13.3.1 CHINA
    • 13.3.1.1 Health-related concerns to boost consumption of personalized nutrition products
  • 13.3.2 JAPAN
    • 13.3.2.1 Aging population to drive demand for personalized nutrition
  • 13.3.3 INDIA
    • 13.3.3.1 Surge in cardiovascular mortality and changing trends in population demographics to drive market
  • 13.3.4 AUSTRALIA & NEW ZEALAND
    • 13.3.4.1 Integrated digital health adoption and preventive care partnerships
  • 13.3.5 REST OF ASIA PACIFIC
• 13.4 EUROPE
  • 13.4.1 GERMANY
    • 13.4.1.1 Aging population to drive demand for personalized solutions
  • 13.4.2 UK
    • 13.4.2.1 Increasing health consciousness among consumers to drive growth
  • 13.4.3 FRANCE
    • 13.4.3.1 Increasing trend of adopting high-nutrition diets to drive market
  • 13.4.4 ITALY
    • 13.4.4.1 Growing inclination of consumers toward sports nutrition to positively impact market
  • 13.4.5 SPAIN
    • 13.4.5.1 Growing interest in maintaining healthy lifestyle to drive market
  • 13.4.6 DENMARK
    • 13.4.6.1 Public-sector openness to preventive programs to create early institutional demand
  • 13.4.7 NETHERLANDS
    • 13.4.7.1 High digital health adoption and insurer experiments enable rapid payer pathways
  • 13.4.8 REST OF EUROPE
• 13.5 SOUTH AMERICA
  • 13.5.1 ARGENTINA
    • 13.5.1.1 Strong clinical diagnostics infrastructure and physician-led nutrition culture to boost demand
  • 13.5.2 BRAZIL
    • 13.5.2.1 Large consumer base and mature supplement retail ecosystem to drive market
  • 13.5.3 REST OF SOUTH AMERICA
• 13.6 REST OF THE WORLD (ROW)
  • 13.6.1 AFRICA
    • 13.6.1.1 Health system partnerships and urban premium demand to boost market
  • 13.6.2 MIDDLE EAST
    • 13.6.2.1 High per-capita health spend and employer adoption to drive market

14 COMPETITIVE LANDSCAPE

• 14.1 OVERVIEW
• 14.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
• 14.3 REVENUE ANALYSIS, 2020-2024
• 14.4 MARKET SHARE ANALYSIS, 2024
• 14.5 COMPANY VALUATION AND FINANCIAL MATRIX
• 14.6 BRAND/PRODUCT COMPARISON
  • 14.6.1 ABBOTT
  • 14.6.2 MEDTRONIC
  • 14.6.3 NESTLE
  • 14.6.4 PRENETICS
  • 14.6.5 ZOE
• 14.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
  • 14.7.1 STARS
  • 14.7.2 EMERGING LEADERS
  • 14.7.3 PERVASIVE PLAYERS
  • 14.7.4 PARTICIPANTS
  • 14.7.5 COMPANY FOOTPRINT: KEY PLAYERS
    • 14.7.5.1 Company footprint
    • 14.7.5.2 Region footprint
    • 14.7.5.3 Solution type footprint
    • 14.7.5.4 Application footprint
    • 14.7.5.5 End-use footprint
• 14.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
  • 14.8.1 PROGRESSIVE COMPANIES
  • 14.8.2 RESPONSIVE COMPANIES
  • 14.8.3 DYNAMIC COMPANIES
  • 14.8.4 STARTING BLOCKS
• 14.9 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
  • 14.9.1 DETAILED LIST OF KEY START-UPS/SMES
• 14.10 COMPETITIVE SCENARIO AND TRENDS
  • 14.10.1 PRODUCT LAUNCHES
  • 14.10.2 DEALS
  • 14.10.3 EXPANSIONS
  • 14.10.4 OTHER DEVELOPMENTS

15 COMPANY PROFILES

• 15.1 PRODUCT COMPANIES
  • 15.1.1 KEY PLAYERS
    • 15.1.1.1 Abbott
      • 15.1.1.1.1 Business overview
      • 15.1.1.1.2 Products/Solutions/Services offered
      • 15.1.1.1.3 Recent developments
        • 15.1.1.1.3.1 Deals
        • 15.1.1.1.3.2 Other developments
      • 15.1.1.1.4 MnM view
        • 15.1.1.1.4.1 Key strengths/Right to win
        • 15.1.1.1.4.2 Strategic choices
        • 15.1.1.1.4.3 Weaknesses/Competitive threats
    • 15.1.1.2 Nestle
      • 15.1.1.2.1 Business overview
      • 15.1.1.2.2 Products/Solutions/Services offered
      • 15.1.1.2.3 Recent developments
        • 15.1.1.2.3.1 Product launches
        • 15.1.1.2.3.2 Deals
        • 15.1.1.2.3.3 Other developments
      • 15.1.1.2.4 MnM view
        • 15.1.1.2.4.1 Key strengths/Right to win
        • 15.1.1.2.4.2 Strategic choices
        • 15.1.1.2.4.3 Weaknesses/Competitive threats
    • 15.1.1.3 Rootine
      • 15.1.1.3.1 Business overview
      • 15.1.1.3.2 Products/Solutions/Services offered
    • 15.1.1.4 Viome
      • 15.1.1.4.1 Business overview
      • 15.1.1.4.2 Products/Solutions/Services offered
      • 15.1.1.4.3 Recent developments
        • 15.1.1.4.3.1 Product launches
        • 15.1.1.4.3.2 Deals
    • 15.1.1.5 Seed Health
      • 15.1.1.5.1 Business overview
      • 15.1.1.5.2 Products/Solutions/Services offered
      • 15.1.1.5.3 Recent developments
        • 15.1.1.5.3.1 Product launches
        • 15.1.1.5.3.2 Other developments
    • 15.1.1.6 myDNA
      • 15.1.1.6.1 Business overview
      • 15.1.1.6.2 Products/Solutions/Services offered
      • 15.1.1.6.3 Recent developments
        • 15.1.1.6.3.1 Deals
    • 15.1.1.7 Superpower
      • 15.1.1.7.1 Business overview
      • 15.1.1.7.2 Products/Solutions/Services offered
      • 15.1.1.7.3 Recent developments
        • 15.1.1.7.3.1 Deals
    • 15.1.1.8 Ombre
      • 15.1.1.8.1 Business overview
      • 15.1.1.8.2 Products/Solutions/Services offered
    • 15.1.1.9 Sun Genomics
      • 15.1.1.9.1 Business overview
      • 15.1.1.9.2 Products/Solutions/Services offered
      • 15.1.1.9.3 Recent developments
        • 15.1.1.9.3.1 Deals
    • 15.1.1.10 GenoPalate
      • 15.1.1.10.1 Business overview
      • 15.1.1.10.2 Products/Solutions/Services offered
      • 15.1.1.10.3 Recent developments
        • 15.1.1.10.3.1 Product launches
        • 15.1.1.10.3.2 Deals
  • 15.1.2 OTHER PLAYERS
    • 15.1.2.1 Nature's Way
      • 15.1.2.1.1 Business overview
      • 15.1.2.1.2 Products/Solutions/Services offered
      • 15.1.2.1.3 Recent developments
        • 15.1.2.1.3.1 Deals
    • 15.1.2.2 Vitaminlab
      • 15.1.2.2.1 Business overview
      • 15.1.2.2.2 Products/Solutions/Services offered
    • 15.1.2.3 Cuure
      • 15.1.2.3.1 Business overview
      • 15.1.2.3.2 Products/Solutions/Services offered
    • 15.1.2.4 Thorne Healthtech
      • 15.1.2.4.1 Business overview
      • 15.1.2.4.2 Products/Solutions/Services offered
      • 15.1.2.4.3 Recent developments
        • 15.1.2.4.3.1 Deals
    • 15.1.2.5 Vitagene
      • 15.1.2.5.1 Business overview
      • 15.1.2.5.2 Products/Solutions/Services offered
• 15.2 SERVICE COMPANIES
  • 15.2.1 KEY PLAYERS
    • 15.2.1.1 23andMe
      • 15.2.1.1.1 Business overview
      • 15.2.1.1.2 Products/Solutions/Services offered
      • 15.2.1.1.3 Recent developments
        • 15.2.1.1.3.1 Product launches
        • 15.2.1.1.3.2 Deals
      • 15.2.1.1.4 MnM View
        • 15.2.1.1.4.1 Key strengths/Right to win
        • 15.2.1.1.4.2 Strategic choices
        • 15.2.1.1.4.3 Weaknesses/Competitive threats
    • 15.2.1.2 Medtronic
      • 15.2.1.2.1 Business overview
      • 15.2.1.2.2 Products/Solutions/Services offered
      • 15.2.1.2.3 Recent developments
        • 15.2.1.2.3.1 Deals
      • 15.2.1.2.4 MnM view
        • 15.2.1.2.4.1 Key strengths/right to win
        • 15.2.1.2.4.2 Strategic choices
        • 15.2.1.2.4.3 Weaknesses/Competitive threats
    • 15.2.1.3 Prenetics
      • 15.2.1.3.1 Business overview
      • 15.2.1.3.2 Products/Solutions/Services offered
      • 15.2.1.3.3 Recent developments
        • 15.2.1.3.3.1 Product launches
        • 15.2.1.3.3.2 Deals
      • 15.2.1.3.4 MnM View
        • 15.2.1.3.4.1 Key strengths/Right to win
        • 15.2.1.3.4.2 Strategic choices
        • 15.2.1.3.4.3 Weaknesses Competitive threats
    • 15.2.1.4 Zoe
      • 15.2.1.4.1 Business overview
      • 15.2.1.4.2 Products/Solutions/Services offered
      • 15.2.1.4.3 Recent developments
        • 15.2.1.4.3.1 Other developments
• 15.3 OTHER PLAYERS
  • 15.3.1 INSIDE TRACKER
    • 15.3.1.1 Business overview
    • 15.3.1.2 Products/Solutions/Services offered
    • 15.3.1.3 Recent developments
      • 15.3.1.3.1 Product launches
      • 15.3.1.3.2 Deals
      • 15.3.1.3.3 Other developments
  • 15.3.2 NUTRIGENOMIX
    • 15.3.2.1 Business overview
    • 15.3.2.2 Products/Solutions/Services offered
    • 15.3.2.3 Recent developments
      • 15.3.2.3.1 Deals
  • 15.3.3 SUGGESTIC
    • 15.3.3.1 Business overview
    • 15.3.3.2 Products/Solutions/Services offered
  • 15.3.4 LEVELS
    • 15.3.4.1 Business overview
    • 15.3.4.2 Products/Solutions/Services offered
  • 15.3.5 OVIVA
    • 15.3.5.1 Business overview
    • 15.3.5.2 Products/Solutions/Services offered
  • 15.3.6 NOOM
    • 15.3.6.1 Business overview
    • 15.3.6.2 Products/Solutions/Services offered
    • 15.3.6.3 Recent developments
      • 15.3.6.3.1 Product launches
      • 15.3.6.3.2 Deals
  • 15.3.7 CAREPREDICT
  • 15.3.8 SELFDECODE
  • 15.3.9 NUTRIGENIE
  • 15.3.10 SEASON HEALTH
  • 15.3.11 ALBA HEALTH

16 ADJACENT AND RELATED MARKETS

• 16.1 INTRODUCTION
• 16.2 LIMITATIONS
• 16.3 PRECISION NUTRITION MARKET
  • 16.3.1 MARKET DEFINITION
  • 16.3.2 MARKET OVERVIEW
• 16.4 DIETARY SUPPLEMENTS MARKET
  • 16.4.1 MARKET DEFINITION
  • 16.4.2 MARKET OVERVIEW

17 APPENDIX

• 17.1 DISCUSSION GUIDE
• 17.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 17.3 CUSTOMIZATION OPTIONS
• 17.4 RELATED REPORTS
• 17.5 AUTHOR DETAILS